Investor's Business Daily on MSN
The gene-editing news that sent beleaguered Intellia Therapeutics stock up
Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.
News Medical on MSN
First topical CRISPR gene therapy corrects disease-causing mutations in human skin
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Morning Overview on MSN
Gene editing breakthrough could kill off daily cholesterol pills
For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...
From projects examining healthcare initiative impacts to groundbreaking medical developments, the forum — which annually ...
Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...
A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday. The study, which ...
Pneumocystis is an unwieldy genus of fungal pathogens that cause severe pneumonia, particularly in immunocompromised people ...
TEK IMAGE/Science Photo Library / Getty Images/Science Photo Libra A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results